Sign in or Register   Sign in or Register
  |  

Mouse Anti-DEAF1 Recombinant Antibody (349C4a) (CBMAB-D0638-YC)

Provided herein is a Mouse monoclonal antibody, which binds to DEAF1, Transcription Factor (DEAF1). The antibody can be used for immunoassay techniques, such as Dot.
See all DEAF1 antibodies

Summary

Host Animal
Mouse
Specificity
Human
Clone
349C4a
Antibody Isotype
IgG1
Application
Dot

Basic Information

Immunogen
Recombinant Human Deformed Epidermal Autoregulatory Factor 1 (Drosophila)
Specificity
Human
Antibody Isotype
IgG1
Clonality
Monoclonal
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Storage
Store at 4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

Full Name
DEAF1
Introduction
DEAF1 is a zinc finger domain-containing protein that functions as a regulator of transcription. The encoded proteins binds to its own promoter as well as to that of several target genes. Activity of this protein is important in the regulation of embryonic development. Mutations in this gene have been found in individuals with autosomal dominant cognitive disability.
Entrez Gene ID
10522
UniProt ID
O75398
Alternative Names
DEAF1, Transcription Factor; Nuclear DEAF-1-Related Transcriptional Regulator; Zinc Finger MYND Domain-Containing Protein 5; Suppressin; ZMYND5; NUDR;
Function
Transcription factor that binds to sequence with multiple copies of 5'-TTC[CG]G-3' present in its own promoter and that of the HNRPA2B1 gene. Down-regulates transcription of these genes. Binds to the retinoic acid response element (RARE) 5'-AGGGTTCACCGAAAGTTCA-3'. Activates the proenkephalin gene independently of promoter binding, probably through protein-protein interaction. When secreted, behaves as an inhibitor of cell proliferation, by arresting cells in the G0 or G1 phase. Required for neural tube closure and skeletal patterning. Regulates epithelial cell proliferation and side-branching in the mammary gland. Controls the expression of peripheral tissue antigens in pancreatic lymph nodes. Isoform 1 displays greater transcriptional activity than isoform 4. Isoform 4 may inhibit transcriptional activity of isoform 1 by interacting with isoform 1 and retaining it in the cytoplasm. Transcriptional activator of EIF4G3.
Biological Process
Anatomical structure morphogenesis Source: ProtInc
Embryonic skeletal system development Source: UniProtKB
Germ cell development Source: ProtInc
Negative regulation of transcription, DNA-templated Source: UniProtKB
Negative regulation of transcription by RNA polymerase II Source: NTNU_SB
Neural tube closure Source: UniProtKB
Positive regulation of transcription, DNA-templated Source: UniProtKB
Regulation of mammary gland epithelial cell proliferation Source: UniProtKB
Regulation of transcription by RNA polymerase II Source: GO_Central
Transcription by RNA polymerase II Source: ProtInc
Cellular Location
Isoform 1: Nucleus; Cytoplasm. Cytoplasmic in non-mucinous colorectal carcinoma. When expressed alone, localized almost exclusively in the nucleus but, when expressed with isoform 4, nuclear expression decreases to 32% and cytoplasmic expression increases by 270%.
Isoform 2&3: Secreted. Secreted in some cell types.
Isoform 4: Nucleus; Cytoplasm. When expressed alone, localizes mainly in the cytoplasm but, when expressed with isoform 1, nuclear localization is enhanced.
Involvement in disease
Vulto-van Silfout-de Vries syndrome (VSVS):
An autosomal dominant disorder characterized by intellectual disability, poor speech, motor delay, and autistic features. Most patients have additional non-specific features, including hypotonia and gait abnormalities, seizures, which may be refractory, high pain threshold, and sleep disturbances.
Neurodevelopmental disorder with hypotonia, impaired expressive language, and with or without seizures (NEDHELS):
An autosomal recessive disorder characterized by psychomotor delay, epilepsy, intellectual disability, speech impairment and dyskinesia of the limbs. Patients also manifest autistic features and other behavioral abnormalities.
PTM
May be phosphorylated by DNA-PK complex in a DNA independent manner (in vitro).

Chen, S., Deng, X., Xiong, J., He, F., Yang, L., Chen, B., ... & Yin, F. (2021). De novo variants of DEAF1 cause intellectual disability in six Chinese patients. Clinica Chimica Acta, 518, 17-21.

McGee, S. R., Rose, G. M., & Jensik, P. J. (2020). Impaired memory and marble burying activity in deformed epidermal autoregulatory factor 1 (Deaf1) conditional knockout mice. Behavioural Brain Research, 380, 112383.

Aronsen, D. R. (2020). ChIP-seq analysis of AIRE, FEZF2 and DEAF1 transcription factors in human thymus tissue (Master's thesis, Norwegian University of Life Sciences, Ås).

Andoni, T., Ellard, S., Kapadia, J., & Wakeling, E. (2020). A novel autosomal recessive DEAF1 nonsense variant: expanding the clinical phenotype. Clinical Dysmorphology, 29(2), 114-117.

Aldea, D., Kokalari, B., Luckhart, C., Aharoni, A., Albert, P. R., & Kamberov, Y. G. (2019). The transcription factor Deaf1 modulates engrailed-1 expression to regulate skin appendage fate. Journal of Investigative Dermatology, 139(11), 2378-2381.

Nabais Sá, M. J., Jensik, P. J., McGee, S. R., Parker, M. J., Lahiri, N., McNeil, E. P., ... & Vulto-vanSilfhout, A. T. (2019). De novo and biallelic DEAF1 variants cause a phenotypic spectrum. Genetics in Medicine, 21(9), 2059-2069.

Chen, L., Jensik, P. J., Alaimo, J. T., Walkiewicz, M., Berger, S., Roeder, E., ... & Elsea, S. H. (2017). Functional analysis of novel DEAF1 variants identified through clinical exome sequencing expands DEAF1‐associated neurodevelopmental disorder (DAND) phenotype. Human mutation, 38(12), 1774-1785.

Pérez-Zamorano, B., Rosas-Madrigal, S., Lozano, O. A. M., Castillo Méndez, M., & Valverde-Garduño, V. (2017). Identification of cis-regulatory sequences reveals potential participation of lola and Deaf1 transcription factors in Anopheles gambiae innate immune response. PloS one, 12(10), e0186435.

Ask a question We look forward to hearing from you.
0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Loading...
Have you used Mouse Anti-DEAF1 Recombinant Antibody (349C4a)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Documents

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

Go to
Compare